These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A Plasmodium falciparum ubiquitin-specific protease (PfUSP) is essential for parasite survival and its disruption enhances artemisinin efficacy. Arora P; Narwal M; Thakur V; Mukhtar O; Malhotra P; Mohmmed A Biochem J; 2023 Jan; 480(1):25-39. PubMed ID: 36511651 [TBL] [Abstract][Full Text] [Related]
5. Local emergence in Amazonia of Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L Elife; 2020 May; 9():. PubMed ID: 32394893 [TBL] [Abstract][Full Text] [Related]
6. Artemisinin Action and Resistance in Plasmodium falciparum. Tilley L; Straimer J; Gnädig NF; Ralph SA; Fidock DA Trends Parasitol; 2016 Sep; 32(9):682-696. PubMed ID: 27289273 [TBL] [Abstract][Full Text] [Related]
7. Protein Degradation Systems as Antimalarial Therapeutic Targets. Ng CL; Fidock DA; Bogyo M Trends Parasitol; 2017 Sep; 33(9):731-743. PubMed ID: 28688800 [TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome Inhibitors. Zhang H; Ginn J; Zhan W; Liu YJ; Leung A; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Michino M; Vendome J; Beuming T; Sato K; Aso K; Meinke PT; Nathan CF; Kirkman LA; Lin G J Med Chem; 2022 Jul; 65(13):9350-9375. PubMed ID: 35727231 [TBL] [Abstract][Full Text] [Related]
9. Mutation in the 26S proteasome regulatory subunit Gonçalves AF; Lima-Pinheiro A; Teixeira M; Cassiano GC; Cravo P; Ferreira PE Front Cell Infect Microbiol; 2024; 14():1342856. PubMed ID: 38404287 [TBL] [Abstract][Full Text] [Related]
14. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses. Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352 [TBL] [Abstract][Full Text] [Related]
15. PfHDAC1 is an essential regulator of Kanyal A; Deshmukh B; Davies H; Mamatharani DV; Farheen D; Treeck M; Karmodiya K mBio; 2024 Jun; 15(6):e0237723. PubMed ID: 38709067 [TBL] [Abstract][Full Text] [Related]
16. Tolerance of Gambian Plasmodium falciparum to Dihydroartemisinin and Lumefantrine Detected by Mbye H; Bojang F; Jawara AS; Njie B; Mohammed NI; Okebe J; D'Alessandro U; Amambua-Ngwa A Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33020162 [TBL] [Abstract][Full Text] [Related]
17. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents. Stokes BH; Yoo E; Murithi JM; Luth MR; Afanasyev P; da Fonseca PCA; Winzeler EA; Ng CL; Bogyo M; Fidock DA PLoS Pathog; 2019 Jun; 15(6):e1007722. PubMed ID: 31170268 [TBL] [Abstract][Full Text] [Related]
18. A Variant PfCRT Isoform Can Contribute to Dhingra SK; Redhi D; Combrinck JM; Yeo T; Okombo J; Henrich PP; Cowell AN; Gupta P; Stegman ML; Hoke JM; Cooper RA; Winzeler E; Mok S; Egan TJ; Fidock DA mBio; 2017 May; 8(3):. PubMed ID: 28487425 [TBL] [Abstract][Full Text] [Related]
19. Experimentally Engineered Mutations in a Ubiquitin Hydrolase, UBP-1, Modulate Simwela NV; Hughes KR; Roberts AB; Rennie MT; Barrett MP; Waters AP Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340987 [TBL] [Abstract][Full Text] [Related]
20. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa? Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]